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Abstract
Diets enriched with advanced glycation end products (AGE) have recently been related to muscle dysfunction processes. However, it remains
unclear whether long-term exposure to an AGE-enriched diet impacts physiological characteristics of skeletal muscles. Therefore, we explored
the differences in skeletal muscle mass, contractile function and molecular responses between mice receiving a diet high in AGE (H-AGE) and
low in AGE (L-AGE) for 16 weeks. There were no signiﬁcant differences between L-AGE and H-AGE mice with regard to body weight, food
intake or epididymal fat pad weight. However, extensor digitorum longus (EDL) and plantaris (PLA) muscle weights in H-AGE mice were
lower compared with L-AGE mice. Higher levels of Nε-(carboxymethyl)-L-lysine, a marker for AGE, in EDL muscles of H-AGE mice were
observed compared with L-AGE mice. H-AGE mice showed lower muscle strength and endurance in vivo and lower muscle force production
of PLA muscle in vitro. mRNA expression levels of myogenic factors including myogenic factor 5 and myogenic differentiation in EDL muscle
were lower in H-AGE mice compared with L-AGE mice. The phosphorylation status of 70-kDa ribosomal protein S6 kinase Thr389, an indicator
of protein synthesis signalling, was lower in EDL muscle of H-AGE mice than that of L-AGE mice. These ﬁndings suggest that long-term
exposure to an AGE-enriched diet impairs skeletal muscle growth and muscle contractile function, and that these muscle dysfunctions may be
attributed to the inhibition of myogenic potential and protein synthesis.
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Skeletal muscles, which account for approximately 40% of total
body mass, are the largest tissue in the body and play a crucial
role in locomotion and metabolism. Both skeletal muscle mass
and function are regulated in response to changes in nutrition,
physical activity, environment and pathological conditions.
Maintenance of muscle mass and function is an important
public health issue, as low muscle quality is associated with
clinical problems including poor glycaemic control, limited
mobility and even mortality(1,2).
Advanced glycation end products (AGE), which are produced
by a non-enzymatic reaction between glucose and proteins, are
closely involved in the pathogenesis of diabetes(3,4), Alzheimer
disease(5), cancer(6) and hypertension(7). Moreover, elevated
AGE in blood or skin are related to low muscle mass, grip
strength and walking speed in elderly and diabetic patients(8–11).
Thus, a negative relationship between AGE and skeletal muscle
function has been suggested.
AGE are endogenously formed but are also absorbed from
exogenous sources such as foods, especially when prepared at
elevated temperatures(12). As dietary AGE are poorly absorbed
(approximately 10%)(13), their potential action in human
health has gone largely unnoticed. However, recent systematic
reviews of randomised-controlled trials have shown that
exposure to AGE-enriched diets may be responsible for the
development of chronic diseases such as diabetes, CVD
and chronic kidney disease through increased inﬂammation
and oxidative stress(14), and that dietary restriction of AGE
alleviates insulin resistance, oxidative stress and endothelial
dysfunction(15). In addition, an AGE-enriched diet induced
insulin resistance in mouse skeletal muscle(16). Thus, we
hypothesised that dietary AGE might impair skeletal muscle
function. However, whether dietary AGE affect physiological
characteristics of skeletal muscle is not yet fully understood.
Therefore, our aim was to evaluate the effect of long-term
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exposure to an AGE-enriched diet on skeletal muscle mass and
contractile functions.
Myogenesis plays an important role in postnatal growth
and skeletal muscle development. Sequential activation and
expression of paired box 7 (Pax7) and myogenic regulatory
factors including myogenic factor 5 (Myf5), myogenic
differentiation (MyoD) and myogenin are essential for the
initiation and progression of myogenesis(17). An in vitro study
revealed that AGE treatment for 48 h suppressed myogenin
expression in C2C12 myotubes(18). Further, an in vivo study
showed that long-term intake of a high-fructose diet decreased
MyoD expression in mouse skeletal muscle, which was
attenuated by supplementation with pyridoxamine, an AGE
formation inhibitor(19). The receptor for AGE also regulates
muscle differentiation through Pax7 and myogenin(20). These
studies suggest that AGE impact the expressions of myogenic
factors and inhibit myogenesis.
Skeletal muscle growth occurs when the rate of protein
synthesis exceeds that of degradation. A central signalling
pathway regulating protein synthesis is the Akt/mammalian
target of rapamycin (mTOR)/70-kDa ribosomal protein S6
kinase (p70S6K) signalling pathway(21). On the other hand,
protein degradation is regulated by two major systems: auto-
phagy and ubiquitin–proteasome systems(22,23). Previously,
AGE treatment was reported to induce autophagy by suppres-
sing the Akt/mTOR pathway in neonatal cardiomyocytes(24). In
addition, a recent study demonstrated that AGE treatment
decreased the phosphorylation status of Akt at Ser473, which is
an indicator of Akt activity, and increased atrogin-1, which is a
key enzyme in the ubiquitin–proteasome system, in C2C12
myotubes(18). These ﬁndings suggest that AGE inhibit protein
synthesis as well as promote protein degradation in skeletal
muscle. Therefore, our secondary aim was to evaluate the
inﬂuence of dietary AGE on the regulatory systems of
myogenesis and protein turnover in skeletal muscle.
We examined the differences in muscle mass, contractile
properties and molecular responses between mice that received
a diet high in AGE (H-AGE) v. one low in AGE (L-AGE) for
16 weeks. We found that Nε-(carboxymethyl)-L-lysine (CML),
a well-characterised compound that serves as a marker for
AGE(25), accumulated in fast-type extensor digitorum longus
(EDL) muscle, and EDL muscle weight was lower in H-AGE
mice compared with L-AGE mice. The contractile proper-
ties were also poorer in H-AGE mice. Furthermore, mRNA
expressions of myogenic factors and phosphorylation status of
mTOR/p70S6K signalling pathway were lower in EDL muscles
of H-AGE mice compared with L-AGE mice.
Methods
Animals and treatment
Male ICR mice (5 weeks old) were purchased from Shimizu
Breeding Laboratories (Kyoto, Japan). Mice were placed in a
room maintained at 22–24°C with a 12 h light–12 h dark cycle
and fed a standard diet (AIN-93G; Oriental Yeast) and water
ad libitum. After 1 week of adjustment, mice were randomised
to receive a diet either low in AGE (AIN-93G unbaked, n 10) or
high in AGE (AIN-93G baked for 1 h at 160°C, n 10) consistent
with previous studies(26–28). The H-AGE diet contained ﬁve
times as much AGE compared with the L-AGE diet without
changes in nutrient composition(28). Both groups were
followed-up for 16 weeks. Body weight and food intake were
measured every week and every 2 weeks, respectively. At the
end of the study period, animals were fasted for 4 h and
anaesthetised intraperitoneally with mixtures of medetomidine
hydrochloride (0·3mg/kg), midazolam (4·0mg/kg) and butor-
phanol (5·0mg/kg). Under anaesthesia, soleus (SOL), EDL and
plantaris (PLA) muscles, tibial, epididymal fat pads and blood
samples were collected. All animal protocols were carried out in
accordance with the Guide for the Care and Use of Laboratory
Animals by the National Institutes of Health (Bethesda, MD,
USA) and were approved by the Kyoto University Graduate
School of Human and Environmental Studies.
Grip strength test
The grip strength test was performed 5 d before the end of
the 16-week study. Grip strength was measured using a force
transducer (DS2-50N; IMADA) according to the published
protocol (DMD_M.2.2.001). In brief, mice were allowed to rest
on a horizontal mesh with their forelimbs and hindlimbs (four
paws) and were then gently pulled back until their grip was
broken. Three consecutive measurements were obtained within
1min, and were averaged to determine mean grip strength.
Data were normalised to body weight and expressed as N/g.
Wire-hanging test
To evaluate muscle fatigue resistance, the wire-hanging test was
carried out 4d before the end of the 16-week study consistent with
the published protocol(29). In brief, mice were suspended by their
forelimbs from a metallic wire (2-mm thick, 50-cm long) suspended
40cm above soft ground. As soon as the mice were suspended, the
timer was started. The timer was stopped when the animal fell and
re-started after it was placed again on the wire. The number of falls
from the wire was recorded, and the test was stopped after ten
falls or 180 s of suspension. Data were expressed as the average fall
score: each animal was given a score of 10 at the beginning of the
test, which was reduced by 1 after each fall. The average fall score
was calculated at a given time during the test as (10n−x)/n, where
n is the number of animals and x the cumulative number of falls.
The longest holding time was also recorded, and the holding
impulse was calculated as s×g, where s is the longest holding time
and g the body weight.
In vitro muscle contraction
In vitro muscle contraction was analysed as described pre-
viously(30,31). Isolated PLA muscles were mounted on an incuba-
tion apparatus with tension set to 0·5g and rested in Krebs–Ringer
bicarbonate buffer (117-mM NaCl, 4·7-mM KCl, 2·5-mM CaCl2,
1·2-mM KH2PO4, 1·2-mM MgSO4, 24·6-mM NaHCO3) containing
2-mM pyruvate for 30min. All buffers were continuously
bubbled with 95% O2–5% CO2 and maintained at 37°C.
For measuring force production, muscles were stimulated using
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an electric stimulator (SEN-3401; Nihon Kohden) at frequencies of
5, 10, 25, 50, 75 and 100Hz (train duration: 1 s; pulse duration:
0·1ms; voltage: 10V) with a 2-min rest period between
contractions(32). Subsequently, for measuring muscle fatigability,
muscles were stimulated at 100Hz, 1-s on 1-s off, for 30 s. Force
was monitored using a force transducer (TRN001; Kent Scientiﬁc)
and recorded (U-228-2P-500; Pantos). Force production data were
normalised to muscle weight and expressed as N/g.
Real-time RT-PCR analyses
Real-time RT-PCR analyses were performed as previously
described(33). In brief, total muscle RNA was extracted using a
miRNeasy Mini kit (Qiagen) according to the manufacturer’s
protocol. RNA was reverse-transcribed to complementary
DNA (cDNA) using PrimeScript RT Master Mix (Takara Bio);
synthesised cDNA was then subjected to real-time RT-PCR
(StepOne, Applied Biosystems) using Takara SYBR Premix Ex
Taq II (Takara Bio). The relative fold change of expression was
calculated by the comparative CT method using StepOne soft-
ware version 2.3. To normalise the amount of total RNA present
in each reaction, glyceraldehyde 3-phosphate dehydrogenase
was used as an internal standard. The primer sequences are
shown in Table 1.
Measurement of myosin heavy chain isoform composition
Analysis of myosin heavy chain (MHC) isoform composition (I, IIa,
IIx and IIb) was carried out using a modiﬁcation of previously
described methods(34). In brief, muscles were homogenised in
ice-cold lysis buffer (1:40, w/v) containing 20-mM Tris·HCl (pH 7·4),
1% Triton X, 50-mM NaCl, 250-mM sucrose, 50-mM NaF, 5-mM
sodium pyrophosphate, 2-mM dithiothreitol, 4-mg/l leupeptin,
50-mg/l trypsin inhibitor, 0·1-mM benzamidine and 0·5-mM
phenylmethylsulphonyl ﬂuoride (buffer A) and centrifuged at
16000g for 40min at 4°C. Extracted proteins were solubilised in
Laemmli sample buffer and boiled for 5min. The sample proteins
(5µg) were separated on SDS-polyacrylamide (7%) gel at
120V for 19h in a temperature-controlled chamber at 4°C.
After electrophoresis, the gels were stained with Oriole™
Fluorescent Gel Stain (Bio-Rad Laboratories). The gels were
visualised using ImageCapture G3 (Liponics) and analysed using
ImageJ software (National Institutes of Health). As we could not
clearly distinguish between the IIa and the IIx MHC bands, this
phenotype was expressed as IIa/x.
Western blot analyses
Western blot analysis was performed as described previously(35,36).
Extracted samples in buffer A were solubilised in Laemmli’s sample
buffer and boiled for 5min. The samples (10µg of protein)
were separated by SDS-PAGE using 10% polyacrylamide gel at
a constant current of 40mA/gel for 90min. After SDS-PAGE, the
proteins were transferred to polyvinylidene ﬂuoride membranes
(Hybond-P; GE Healthcare) by using trans-blot cell (Bio-Rad) at a
constant voltage of 100V for 1h at 4°C. After the transfer, the
membranes were blocked for 1h using ﬁsh gelatin (Takara Bio).
Next, the membranes were incubated overnight at 4°C with pri-
mary antibodies: Akt (9272; Cell Signaling Technology), Akt Ser473
(9271; Cell Signaling Technology), p70S6K (2708; Cell Signaling
Technology), p70S6K Thr389 (9206; Cell Signaling Technology)
and microtubule-associated protein light-chain 3 (LC3) (2775; Cell
Signaling Technology). The membranes were washed with
Tris-buffered saline with 0·1% Tween 20 (TBS-T, pH 7·5) and then
allowed to react with anti-rabbit IgG (Cell Signaling Technology)
for 1h at room temperature. After the ﬁnal wash with TBS-T,
protein bands were visualised using chemiluminescence (Wako).
Signal density was measured using Light-Capture (AE-6971;
ATTO Corporation).
Measurement of Nε-(carboxymethyl)-L-lysine content
The muscle sample was homogenised in buffer A, and the
supernatant was collected after centrifugation at 16000g for 40min
at 4°C. Blood samples were collected from the carotid artery
into tubes containing heparin as anticoagulant, and plasma was
separated by centrifugation at 8000g for 15min. The content of
CML in muscles and plasma was measured using a CircuLex
CML/Nε-(carboxymethyl) lysine ELISA Kit (Medical & Biological
Laboratories) according to the manufacturer’s protocol. Protein
concentration of the supernatant of muscles and plasma was
determined using the Bradford technique, and the CML content in
samples was expressed as µg/mg protein.
Statistical analyses
Values are expressed as means with their standard errors.
Statistical signiﬁcance was analysed using parametric Student’s
t test or non-parametric Mann–Whitney U test (Tables 2–4 and
Fig. 1) and two-way ANOVA with diet and frequencies (Fig. 2)
or diet and muscles (Fig. 3–5) as main factors. In the event of
signiﬁcant main effects and/or interactions, post hoc Tukey–
Kramer tests were performed. Differences between groups
were considered statistically signiﬁcant at P< 0·05. The sample
size was calculated by power analysis at 0·8 and a level of
signiﬁcance of 0·05 with a hypothesised effect size of 1·2
based on the means and variances of muscle mass data in our
Table 1. List of primer sequences (forward, reverse) used for real-time
RT-PCR analyses















Pax7, paired box 7; Myf5, myogenic factor 5; MyoD, myogenic differentiation; MuRF1,
muscle RING finger 1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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previous study(37), which estimated the sample size to be 10. All
statistical analyses were performed using Ekuseru-Toukei 2012
software (Social Survey Research Information).
Results
Dietary advanced glycation end products suppressed
skeletal muscle growth
The characteristics of mice exposed to L-AGE and H-AGE are
shown in Table 2. There were no signiﬁcant differences
between L-AGE and H-AGE mice in body weight, tibial length,
food intake and epididymal fat pad weight. EDL muscle weight
was lower in H-AGE mice compared with L-AGE mice when
normalised to body weight and tibial length. PLA muscle weight
was lower in H-AGE mice when normalised to tibial length
and tended to be lower when normalised to body weight
(P= 0·096). There were no signiﬁcant differences in SOL muscle
weight between L-AGE and H-AGE mice.
Dietary advanced glycation end products increased Nε-
(carboxymethyl)-L-lysine accumulation in skeletal muscle
To evaluate the impact of the H-AGE diet for 16 weeks, we
examined accumulation of CML in skeletal muscles and plasma.
H-AGE mice showed an increase in CML content in EDL muscle
(Table 3). The content in SOL muscle and plasma tended to
increase, but this was not signiﬁcantly different.
Dietary advanced glycation end products deteriorated
muscle performance in vivo
To examine the effect of the H-AGE diet on muscle perfor-
mance, we assessed muscle strength and fatigue resistance in
mice. The grip strength test was used to measure muscle
strength. Grip strength in all four limbs in H-AGE mice was
weaker than in L-AGE mice (Fig. 1(a)). To measure fatigue
resistance, we carried out the wire-hanging test. The average
fall score during the wire-hanging test was 3·7 at the end of the
experiment in L-AGE mice, whereas the score fell faster in
H-AGE mice and reached 1·4 (Fig. 1(b)). The longest holding
time during the wire-hanging test was shorter by 30% in H-AGE
mice compared with L-AGE mice; holding impulse was sig-
niﬁcantly lower in H-AGE mice than in L-AGE mice (Fig. 1(c)).
Dietary advanced glycation end products deteriorated
muscle force production in vitro
We next measured force production in skeletal muscle in vitro to
determine the effect of H-AGE on muscle contractile property. PLA
muscle of H-AGE mice was found to produce signiﬁcantly lower
force at 75 and 100Hz compared with L-AGE mice (Fig. 2(a)).
There were no signiﬁcant differences in the patterns of force
decline between L-AGE and H-AGE mice (Fig. 2(b)).
Dietary advanced glycation end products did not affect
myosin heavy chain isoform composition in skeletal muscle
As muscle ﬁbre type composition is a determinant of muscle
strength and fatigue resistance, we evaluated the effect of
H-AGE on MHC isoform composition in skeletal muscles.
No signiﬁcant differences were observed in MHC isoform
composition in either SOL or EDL muscles between L-AGE and
H-AGE mice (Table 4)
Dietary advanced glycation end products decreased mRNA
expressions of myogenic factors in skeletal muscle
To determine the effect of H-AGE on regulatory factors related
to skeletal muscle growth, we evaluated the expression levels
of mRNA involved in myogenesis. Myf5 mRNA expression level
was signiﬁcantly decreased in EDL muscle of H-AGE mice
(Fig. 3). In addition, MyoD mRNA expression levels were
lower in H-AGE mice compared with L-AGE mice. Pax7 and
myogenin mRNA expression levels did not differ signiﬁcantly
based on an H-AGE diet.
Dietary advanced glycation end products suppressed
protein synthesis signalling in skeletal muscle
To examine the effect of H-AGE on protein synthesis,
we evaluated the phosphorylation status of Akt/mTOR/p70S6K
Table 2. Characteristics of low in advanced glycation end products
(L-AGE)- and high in AGE (H-AGE)-fed mice
(Mean values with their standard errors; n 10 per group)
L-AGE H-AGE
Mean SE Mean SE
Initial body weight (g) 31·5 0·8 31·5 0·8
Final body weight (g) 53·6 2·5 59·7 4·0
Tibial length (cm) 2·01 0·02 2·06 0·02
Food intake (kJ/d) 79·1 1·7 78·2 1·7
Food intake (kcal/d) 18·9 0·4 18·7 0·4
Tissue weight normalised to tibial length (mg/cm)
SOL 5·8 0·2 5·5 0·2
EDL 7·8 0·3 7·0* 0·2
PLA 12·3 0·3 11·4* 0·4
Epididymal fat pad weight 1077·1 137·4 1215·3 136·4
Tissue weight normalised to body weight (mg/g)
SOL 0·22 0·01 0·20 0·01
EDL 0·30 0·02 0·25* 0·02
PLA 0·46 0·01 0·41 0·03
Epididymal fat pad weight 39·7 4·4 41·6 3·84
SOL, soleus; EDL, extensor digitorum longus; PLA, plantaris.
*P< 0·05 v. L-AGE.
Table 3. Nε-(carboxymethyl)-L-lysine content
(Mean values with their standard errors; n 8–10 per group)
L-AGE (μg/mg protein) H-AGE (μg/mg protein)
Mean SE Mean SE
SOL 0·18 0·01 0·21 0·01
EDL 0·20 0·01 0·28* 0·02
Plasma 0·022 0·006 0·033 0·005
L-AGE, low in advanced glycation end products; H-AGE, high in advanced glycation
end products; SOL, soleus; EDL, extensor digitorum longus; PLA, plantaris.
*P< 0·05 v. L-AGE.
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signalling pathway. The phosphorylation status of Akt
at Ser473 was not affected by the H-AGE diet, but the expression
of phosphorylated p70S6K Thr389, an indicator of mTOR
activity, was lower in H-AGE mice compared with L-AGE mice
(Fig. 4).
Dietary advanced glycation end products had no effect on
protein degradation pathways in skeletal muscle
To analyse the effect of H-AGE on protein degradation, we
evaluated the expression levels of molecules involved in
autophagy and ubiquitin–proteasome systems. The relative
expression levels of LC3II/LC3I, an indicator of autophagy
activity, were not affected by the H-AGE diet (Fig. 5). There
were also no differences between L-AGE and H-AGE mice
with regard to mRNA expressions of atrogin-1 and muscle
RING ﬁnger 1 (MuRF1), another key enzyme of the ubiquitin–
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Fig. 1. The grip strength test and wire-hanging test in mice fed a diet low in
advanced glycation end products (L-AGE) or a diet high in AGE (H-AGE).
(a) Forelimb and hindlimb (four paws) grip strength. (b) Average fall score
during the wire-hanging test. (c) Longest holding time and holding impulse
during the wire-hanging test. The grip strength test and wire-hanging test were
carried out 5 and 4d before the end of the 16-week study, respectively. Values
are means (n 10 per group), with their standard errors. *P< 0·05 v. L-AGE
















































Fig. 2. In vitro force production and fatigability of plantaris muscles in L-AGE
or H-AGE mice. (a) Force generation in response to electrical stimulation.
(b) Percentage of force drop during fifteen contraction cycles. Isolated plantaris
muscle was allowed to rest for 30min, and the muscle was tetanically
contracted at frequencies of 0, 5, 10, 25, 50, 75 and 100Hz with a 2-min rest
between contractions. A fatigue run was then carried out by stimulating the
muscle at 100Hz, 1-s on 1-s off, for 30 s. Values are means (n 10 per group),
with their standard errors. *P< 0·05 v. L-AGE mice. L-AGE, low in advanced
glycation end products; H-AGE, high in AGE; , L-AGE; , H-AGE.
Table 4. Myosin heavy chain (MHC) isoform composition
(Mean values with their standard errors; n 10 per group)
L-AGE H-AGE
Mean SE Mean SE
SOL
MHC I (%) 62·0 2·0 60·3 1·5
MHC IIa/x (%) 38·0 2·0 39·7 1·5
MHC IIb (%) ND ND
EDL
MHC I (%) ND ND
MHC IIa/x (%) 32·7 0·9 33·6 1·4
MHC IIb (%) 67·3 0·9 66·4 1·4
L-AGE, low in advanced glycation end products; H-AGE, high in advanced glycation
end products; SOL, soleus; EDL, extensor digitorum longus.
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Discussion
The results of the present study revealed several novel ﬁndings
about the effects of dietary AGE on skeletal muscle functions.
First, mice fed an H-AGE diet for 16 weeks exhibited smaller
muscle mass than L-AGE mice, which was accompanied
by CML accumulation in skeletal muscle. Second, exposure
to H-AGE induced skeletal muscle dysfunction, including
muscle strength, fatigue resistance and in vitro muscle force
production, without changes in MHC isoform composition.
Third, mRNA expressions of myogenic factors, Myf5 and MyoD,
in skeletal muscle were lower in H-AGE mice compared with
L-AGE mice. Fourth, phosphorylation status of p70S6K Thr389
was lower in H-AGE mice than in L-AGE mice.
Recently, an epidemiological study has suggested a rela-
tionship between AGE accumulation and skeletal muscle mass
in humans(11). In addition, an experimental study showed that
AGE treatment in cultured muscle cells suppressed MyoD and
promoted atrophy(18). That study also revealed that skeletal
muscle atrophy in diabetic mice was attenuated by treatment
with alagebrium chloride, a breaker of AGE-based cross-
links(18). These observations indicate that AGE are potent
factors that inﬂuence muscle mass. In the present study, H-AGE
mice showed smaller muscle masses of EDL and PLA compared
with L-AGE mice (Table 2), which was accompanied by ele-
vated CML content (Table 3). This is the ﬁrst report of long-term
exposure to an AGE-enriched diet promoting AGE accumula-
tion in skeletal muscles and impaired skeletal muscle growth.
AGE are also related to muscle dysfunction. It has been
reported that elevated blood CML is associated with poor grip
strength(8) and slow walking speed(9). Furthermore, men with
higher skin AGE levels had lower muscle strength and
power(10). In the present study, we found that grip strength and
wire-holding performance were poorer in H-AGE mice
compared with L-AGE mice (Fig. 1). In addition, we showed
that in vitro muscle force production normalised to muscle
weight was lower in H-AGE mice than in L-AGE mice
(Fig. 2(a)). These ﬁndings indicate that dietary AGE affect
muscle contractile properties in addition to muscle mass.
In this regard, some reports have shown that myoﬁbrillar
proteins are subject to glycation modiﬁcation. Glycation of
actomyosin increased with ageing in mice and rats(38).
Glycation of myosin altered ﬁlament formation(39), structure and
ATPase activity(40–42). AGE-modiﬁed actin is also accumulated
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Fig. 4. Relative expressions of protein specific for protein synthesis pathway in
L-AGE or H-AGE mice. Soleus (SOL) and extensor digitorum longus (EDL)
muscles were dissected, and expressions of Akt and phosphorylated Akt
Ser473 (p-Akt), 70-kDa ribosomal protein S6 kinase (p70S6K) and
phosphorylated p70S6K Thr389 (p-p70S6K) were measured using western
blot analyses. Representative immunoblots are also shown. Values are means
(n 10 per group), with their standard errors. †Significant main effect of diet
(L-AGE v. H-AGE mice). L-AGE, low in advanced glycation end products;
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Fig. 5. Relative expressions of protein and mRNA specific for protein
degradation pathway in L-AGE or H-AGE mice. Soleus (SOL) and extensor
digitorum longus (EDL) muscles were dissected, and protein expressions of
microtubule-associated protein light-chain 3 (LC3)-I and II were measured
using western blot analyses, and mRNA expressions of atrogin-1 and muscle
RING finger 1 (MuRF1) were measured using real-time RT-PCR analyses.
Representative immunoblots are also shown. Values are means (n 10 per
group), with their standard errors. L-AGE, low in advanced glycation end
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Fig. 3. Relative expressions of mRNA specific for myogenesis in L-AGE or
H-AGE mice. Soleus (SOL) and extensor digitorum longus (EDL) muscles were
dissected, and expressions of paired box 7 (Pax7), myogenic factor 5 (Myf5),
myogenic differentiation (MyoD) and myogenin were measured using real-time
RT-PCR analyses. Values are means (n 10 per group), with their standard
errors. *P< 0·05 v. L-AGE mice. †Significant main effect of diet (L-AGE v.
H-AGE mice). L-AGE, low in advanced glycation end products; H-AGE, high in
AGE; , L-AGE; , H-AGE.
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contractile proteins such as myosin and actin is a possible
mechanism inducing the loss of muscle contractile properties.
Muscle strength is also affected by muscle ﬁbre type
composition(44). The ﬁbre types based on MHC isoforms
essentially reﬂect muscle contractile properties(45). In the
present study, MHC isoform composition did not differ bet-
ween L-AGE and H-AGE mice (Table 4), indicating that dietary
AGE-induced muscle dysfunction is not attributed to the
alteration of muscle ﬁbre type composition.
In the present study, dietary AGE affected muscle mass more
in fast-type muscles, EDL and PLA, than in slow-type muscles,
SOL (Table 2). This indicates that the susceptibility to AGE
might be dependent on ﬁbre type. Indeed, CML accumulated in
EDL muscle but not in SOL muscle during the 16-week treat-
ment period (Table 3). In addition, previous reports have
shown that AGE accumulation in diabetic rat skeletal muscle
was greater in fast-type ﬁbre(46). These ﬁndings suggest that
dietary AGE promote AGE accumulation preferentially in
fast-type ﬁbres of whole-body muscle, and thereby induce
decreased muscle performance. However, some reports have
shown that the presence of AGE did not differ between ﬁbre
types in diabetic(47) or ageing rats(48). Thus, additional studies
are required to elucidate any dependency on ﬁbre type for AGE
inﬂuence.
Postnatal skeletal muscle growth is regulated by the
sequential expressions of myogenic factors such as Pax7,
Myf5, MyoD and myogenin. Pax7 is the speciﬁc marker for
quiescent and activated muscle satellite cells, which are the
resident skeletal muscle stem cells(49,50). Myf5 is expressed
during embryonic development and integrates various develop-
mental signalling pathways to initiate myogenesis(51). MyoD is
considered a master control gene for MyoD(52); myogenin
participates in later stages of myogenesis and is directly
associated with the differentiation process that leads to
myotube formation and maturation(53,54). In the present study,
Myf5 mRNA expression level in EDL muscle was lower in
H-AGE mice than in L-AGE mice (Fig. 3). Furthermore,
MyoD mRNA expression level was suppressed in H-AGE mice
compared with L-AGE mice. These ﬁndings suggest that
dietary AGE inhibit muscle formation during a relatively
early stage of myogenesis, resulting in muscle growth
deterioration.
MyoD is also a crucial modulator of muscle ﬁbre type. MyoD
binds to an enhancer box (E-box) element in the MHC
promoter and induces its transcription(55). In particular, MyoD
expression is high in fast-type muscle and is involved in the
induction of fast-type ﬁbre phenotype(56). Over-expression of
MyoD has been shown to up-regulate the expression of fast-type
MHC(57). Conversely, MyoD-knock-out mice showed a shift
towards slower ﬁbre phenotype in fast-type muscles(56,58). These
observations raise the possibility that the down-regulation
of MyoD mRNA expression in H-AGE mice induced ﬁbre-type
transition towards a slower muscle phenotype. However, dietary
AGE did not affect MHC isoform composition in the present
study (Table 4). In this respect, some studies have reported
inconsistent shifts in MHC with MyoD expressions(59,60).
Thus, the alteration of MyoD expression may not always be
linked to the shift in MHC isoform distributions.
In addition to myogenesis, protein synthesis and subsequent
accumulation of protein are necessary for skeletal muscle
growth. A previous study indicated that AGE induced myotube
atrophy via inhibition of the Akt pathway(18). In the present
study, the phosphorylation status of p70S6K Thr389 was lower in
EDL muscle of H-AGE mice compared with L-AGE mice,
although no change was observed in Akt Ser473 phosphory-
lation (Fig. 4). These results suggest that dietary AGE affect the
mTOR/p70S6K signalling pathway independently of Akt in
skeletal muscle. On the other hand, AGE may possibly modu-
late protein degradation as noted by previous studies, which
have shown that AGE treatment in cultured skeletal and cardiac
muscles activated autophagy and ubiquitin–proteasome path-
ways(18,24). However, no inﬂuences on the ratio of LC3II:LC3I
and mRNA expressions of atrogin-1 and MuRF1 were observed
(Fig. 5), which suggests that dietary AGE do not affect protein
degradation. Therefore, it is suggested that dietary AGE dete-
riorate skeletal muscle growth by inhibiting protein synthesis.
AGE are generally found in several foods prepared at high
temperatures(12). Therefore, animal models exposed to heat-
treated foods are often used to evaluate the inﬂuence of
AGE in vivo(16,26–28,61–65). However, a limitation in using these
models is that the heat applied may produce unexpected
products in diets. From this perspective, our study cannot
exclude the possibility that products other than AGE may affect
muscle dysfunction. Therefore, further investigations using
inhibitors of AGE accumulation should be conducted to
understand the direct links between AGE and muscle functions.
In conclusion, in the present study, we showed that expo-
sure to an AGE-enriched diet for 16 weeks promoted CML
accumulation in skeletal muscle. Furthermore, we observed
impairment in skeletal muscle functions including skeletal
muscle mass, muscle strength and fatigue resistance in H-AGE
mice compared with L-AGE mice. AGE-enriched diet-associated
skeletal muscle dysfunction might be due to a failure of post-
natal myogenesis and protein synthesis. The present study
shows a possibility that long-term exposure to an AGE-enriched
diet impairs postnatal growth and skeletal muscle development.
Acknowledgements
We thank all the members of the Laboratory of Sports and
Exercise Medicine, Kyoto University and the Laboratory of
Physiology, Toyohashi SOZO University for their help. We also
thank Kyoto University Research Center for Low Temperature
and Materials Sciences for instrumental support.
This study was supported in part by JSPS KAKENHI grant
numbers 26560371 (T. E.), 16K12942 (Y. O.), 16K16450 (S. Y.),
16K13022 (K. G.), 26350818 (K. G.) and 15K01711 (T. H.); JSPS
Fellows (A. G., 14J00286); the Ministry of Agriculture, Forestry
and Fisheries; Integration Research for Agriculture and Inter-
disciplinary Fields (funding agency: Bio-oriented Technology
Research Advancement Institution, NARO) (T. H., 14532022);
the Council for Science, Technology and Innovation; and SIP
(funding agency: NARO) (T. H., 14533567). Additional research
grants were provided by the Nakatomi Foundation (T. E.); the
All Japan Coffee Association (T. E. and K. G.); the Vascular
Dietary advanced glycation end products and skeletal muscle growth 27
https://doi.org/10.1017/S0007114516004591
Downloaded from https:/www.cambridge.org/core. Kyoto University, on 29 May 2017 at 06:17:18, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Disease Research Foundation (T. H.); the Naito Foundation
(K. G.); the Descente Sports Foundation (K. G.); and the Graduate
School of Health Sciences, Toyohashi Sozo University (K. G.).
T. E., K. G. and T. H. were involved in the conception
and design of the study; T. E., S. T. and A. G. performed
experiments; T. E., A. G. and S. Y. analysed the data; T. E.,
Y. O., S. Y., K. G. and T. H. interpreted the results of experi-
ments; T. E. prepared the ﬁgures; T. E., S. Y. and K. G. drafted
the manuscript; T. E., A. G., Y. O, K. G. and T. H. edited and
revised the manuscript; T. E., S. T., A. G., Y. O., S. Y., K. G. and
T. H. approved the ﬁnal version of the manuscript.
The authors have no conﬂicts of interest to declare.
References
1. Newman AB, Kupelian V, Visser M, et al. (2006) Strength, but
not muscle mass, is associated with mortality in the health,
aging and body composition study cohort. J Gerontol A Biol
Sci Med Sci 61, 72–77.
2. Park SW, Goodpaster BH, Strotmeyer ES, et al. (2006)
Decreased muscle strength and quality in older adults
with type 2 diabetes: the health, aging, and body
composition study. Diabetes 55, 1813–1818.
3. Vlassara H & Uribarri J (2014) Advanced glycation end
products (AGE) and diabetes: cause, effect, or both?
Curr Diab Rep 14, 453.
4. Bohlender JM, Franke S, Stein G, et al. (2005) Advanced
glycation end products and the kidney. Am J Physiol Renal
Physiol 289, F645–F659.
5. Takeuchi M & Yamagishi S (2008) Possible involvement of
advanced glycation end-products (AGEs) in the pathogenesis
of Alzheimer’s disease. Curr Pharm Design 14, 973–978.
6. van Heijst JW, Niessen HW, Hoekman K, et al. (2005)
Advanced glycation end products in human cancer tissues:
detection of N epsilon-(carboxymethyl)lysine and arg-
pyrimidine. Ann N Y Acad Sci 1043, 725–733.
7. McNulty M, Mahmud A & Feely J (2007) Advanced glycation
end-products and arterial stiffness in hypertension. Am J
Hypertens 20, 242–247.
8. Dalal M, Ferrucci L, Sun K, et al. (2009) Elevated serum
advanced glycation end products and poor grip strength in
older community-dwelling women. J Gerontol A Biol Sci Med
Sci 64, 132–137.
9. Semba RD, Bandinelli S, Sun K, et al. (2010) Relationship of an
advanced glycation end product, plasma carboxymethyl-
lysine, with slow walking speed in older adults: the
InCHIANTI study. Eur J Appl Physiol 108, 191–195.
10. Momma H, Niu K, Kobayashi Y, et al. (2011) Skin advanced
glycation end product accumulation and muscle strength
among adult men. Eur J Appl Physiol 111, 1545–1552.
11. Kato M, Kubo A, Sugioka Y, et al. (2016) Relationship
between advanced glycation end-product accumulation and
low skeletal muscle mass in Japanese men and women.
Geriatr Gerontol Int.
12. O’Brien J & Morrissey PA (1989) Nutritional and toxicological
aspects of the Maillard browning reaction in foods. Crit Rev
Food Sci Nutr 28, 211–248.
13. Koschinsky T, He CJ, Mitsuhashi T, et al. (1997) Orally
absorbed reactive glycation products (glycotoxins): an envir-
onmental risk factor in diabetic nephropathy. Proc Natl Acad
Sci U S A 94, 6474–6479.
14. Clarke RE, Dordevic AL, Tan SM, et al. (2016) Dietary
advanced glycation end products and risk factors for chronic
disease: a systematic review of randomised controlled trials.
Nutrients 8, 125.
15. Kellow NJ & Savige GS (2013) Dietary advanced gly-
cation end-product restriction for the attenuation of insulin
resistance, oxidative stress and endothelial dysfunction:
a systematic review. Eur J Clin Nutr 67, 239–248.
16. Cassese A, Esposito I, Fiory F, et al. (2008) In skeletal muscle
advanced glycation end products (AGEs) inhibit insulin
action and induce the formation of multimolecular
complexes including the receptor for AGEs. J Biol Chem 283,
36088–36099.
17. Bentzinger CF, Wang YX & Rudnicki MA (2012) Building
muscle: molecular regulation of myogenesis. Cold Spring
Harbor Perspect Biol 4, a008342.
18. Chiu CY, Yang RS, Sheu ML, et al. (2016) Advanced glycation
end-products induce skeletal muscle atrophy and dysfunction
in diabetic mice via a RAGE-mediated, AMPK-down-regulated,
Akt pathway. J Pathol 238, 470–482.
19. Mastrocola R, Nigro D, Chiazza F, et al. (2016) Fructose-
derived advanced glycation end-products drive lipogenesis
and skeletal muscle reprogramming via SREBP-1c dysregula-
tion in mice. Free Radic Biol Med 91, 224–235.
20. Riuzzi F, Sorci G, Sagheddu R, et al. (2012) HMGB1-RAGE
regulates muscle satellite cell homeostasis through p38-MAPK-
and myogenin-dependent repression of Pax7 transcription.
J Cell Sci 125, 1440–1454.
21. Miyazaki M & Esser KA (2009) Cellular mechanisms regulating
protein synthesis and skeletal muscle hypertrophy in animals.
J Appl Physiol 106, 1367–1373.
22. Masiero E, Agatea L, Mammucari C, et al. (2009) Autophagy
is required to maintain muscle mass. Cell Metab 10,
507–515.
23. Bonaldo P & Sandri M (2013) Cellular and molecular
mechanisms of muscle atrophy. Dis Model Mech 6, 25–39.
24. Hou X, Hu Z, Xu H, et al. (2014) Advanced glycation end-
products trigger autophagy in cadiomyocyte via RAGE/PI3K/
AKT/mTOR pathway. Cardiovasc Diabetol 13, 78.
25. Ikeda K, Higashi T, Sano H, et al. (1996) N (epsilon)-
(carboxymethyl)lysine protein adduct is a major immuno-
logical epitope in proteins modiﬁed with advanced glycation
end products of the Maillard reaction. Biochemistry 35,
8075–8083.
26. Tan AL, Sourris KC, Harcourt BE, et al. (2010) Disparate effects
on renal and oxidative parameters following RAGE deletion,
AGE accumulation inhibition, or dietary AGE control in
experimental diabetic nephropathy. Am J Physiol Renal
Physiol 298, F763–F770.
27. Sourris KC, Harcourt BE, Penfold SA, et al. (2010) Modulation
of the cellular expression of circulating advanced glycation
end-product receptors in type 2 diabetic nephropathy.
Exp Diabetes Res 2010, 974681.
28. Forbes JM, Cowan SP, Andrikopoulos S, et al. (2013) Glucose
homeostasis can be differentially modulated by varying
individual components of a western diet. J Nutr Biochem 24,
1251–1257.
29. Raymackers JM, Debaix H, Colson-Van Schoor M, et al.
(2003) Consequence of parvalbumin deﬁciency in the
mdx mouse: histological, biochemical and mechanical
phenotype of a new double mutant. Neuromuscul Disord 13,
376–387.
30. Toyoda T, Tanaka S, Ebihara K, et al. (2006) Low-intensity
contraction activates the alpha1-isoform of 5’-AMP-activated
protein kinase in rat skeletal muscle. Am J Physiol Endocrinol
Metab 290, E583–E590.
31. Tsuda S, Egawa T, Kitani K, et al. (2015) Caffeine and
contraction synergistically stimulate 5’-AMP-activated protein
28 T. Egawa et al.
https://doi.org/10.1017/S0007114516004591
Downloaded from https:/www.cambridge.org/core. Kyoto University, on 29 May 2017 at 06:17:18, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
kinase and insulin-independent glucose transport in rat
skeletal muscle. Physiol Rep 3, e12592.
32. Head SI, Greenaway B & Chan S (2011) Incubating isolated
mouse EDL muscles with creatine improves force production
and twitch kinetics in fatigue due to reduction in ionic
strength. PLoS ONE 6, e22742.
33. Yasuhara K, Ohno Y, Kojima A, et al. (2011) Absence of heat
shock transcription factor 1 retards the regrowth of atrophied
soleus muscle in mice. J Appl Physiol 111, 1142–1149.
34. Talmadge RJ & Roy RR (1993) Electrophoretic separation of rat
skeletal muscle myosin heavy-chain isoforms. J Appl Physiol
75, 2337–2340.
35. Ohno Y, Yamada S, Sugiura T, et al. (2011) Possible role of
NF-kB signals in heat stress-associated increase in protein
content of cultured C2C12 cells. Cells Tissues Organs 194,
363–370.
36. Egawa T, Tsuda S, Ma X, et al. (2011) Caffeine modulates
phosphorylation of insulin receptor substrate-1 and impairs
insulin signal transduction in rat skeletal muscle. J Appl Physiol
111, 1629–1636.
37. Egawa T, Goto A, Ohno Y, et al. (2015) Involvement of
AMPK in regulating slow-twitch muscle atrophy during hind-
limb unloading in mice. Am J Physiol Endocrinol Metab 309,
E651–E662.
38. Watanabe H, Ogasawara M, Suzuki N, et al. (1992) Glycation
of myoﬁbrillar protein in aged rats and mice. Biosci Biotechnol
Biochem 56, 1109–1112.
39. Katayama S, Haga Y & Saeki H (2004) Loss of ﬁlament-
forming ability of myosin by non-enzymatic glycosylation and
its molecular mechanism. FEBS Lett 575, 9–13.
40. Syrovy I & Hodny Z (1992) Non-enzymatic glycosylation of
myosin: effects of diabetes and ageing. Gen Physiol Biophys
11, 301–307.
41. Avigad G, Kniep A & Bailin G (1996) Reaction of rabbit
skeletal myosin with D-glucose 6-phosphate. Biochem Mol
Biol Int 40, 273–284.
42. Ramamurthy B, Hook P, Jones AD, et al. (2001) Changes in
myosin structure and function in response to glycation.
FASEB J 15, 2415–2422.
43. Snow LM, Fugere NA & Thompson LV (2007) Advanced
glycation end-product accumulation and associated protein
modiﬁcation in type II skeletal muscle with aging. J Gerontol A
Biol Sci Med Sci 62, 1204–1210.
44. Pette D & Staron RS (2000) Myosin isoforms, muscle ﬁber
types, and transitions. Microsc Res Tech 50, 500–509.
45. Harridge SD, Bottinelli R, Canepari M, et al. (1996)
Whole-muscle and single-ﬁbre contractile properties and
myosin heavy chain isoforms in humans. Pﬂugers Arch 432,
913–920.
46. Snow LM & Thompson LV (2009) Inﬂuence of insulin and
muscle ﬁber type in nepsilon-(carboxymethyl)-lysine accu-
mulation in soleus muscle of rats with streptozotocin-induced
diabetes mellitus. Pathobiology 76, 227–234.
47. Snow LM, Lynner CB, Nielsen EM, et al. (2006) Advanced
glycation end product in diabetic rat skeletal muscle in vivo.
Pathobiology 73, 244–251.
48. Ramamurthy B & Larsson L (2013) Detection of an aging-
related increase in advanced glycation end products in fast-
and slow-twitch skeletal muscles in the rat. Biogerontology 14,
293–301.
49. Seale P, Sabourin LA, Girgis-Gabardo A, et al. (2000) Pax7
is required for the speciﬁcation of myogenic satellite cells.
Cell 102, 777–786.
50. Hawke TJ & Garry DJ (2001) Myogenic satellite cells:
physiology to molecular biology. J Appl Physiol 91, 534–551.
51. Francetic T & Li Q (2011) Skeletal myogenesis and Myf5
activation. Transcription 2, 109–114.
52. Perry RL & Rudnick MA (2000) Molecular mechanisms
regulating myogenic determination and differentiation.
Front Biosci 5, D750–D767.
53. Andres V & Walsh K (1996) Myogenin expression, cell cycle
withdrawal, and phenotypic differentiation are temporally
separable events that precede cell fusion upon myogenesis.
J Cell Biol 132, 657–666.
54. Mak KL, To RQ, Kong Y, et al. (1992) The MRF4 activation
domain is required to induce muscle-speciﬁc gene expression.
Mol Cell Biol 12, 4334–4346.
55. Wheeler MT, Snyder EC, Patterson MN, et al. (1999) An E-box
within the MHC IIB gene is bound by MyoD and is
required for gene expression in fast muscle. Am J Physiol 276,
C1069–C1078.
56. Hughes SM, Koishi K, Rudnicki M, et al. (1997) MyoD protein
is differentially accumulated in fast and slow skeletal muscle
ﬁbres and required for normal ﬁbre type balance in rodents.
Mech Dev 61, 151–163.
57. Ekmark M, Rana ZA, Stewart G, et al. (2007) De-
phosphorylation of MyoD is linking nerve-evoked activity to
fast myosin heavy chain expression in rodent adult
skeletal muscle. J Physiol 584, 637–650.
58. Macharia R, Otto A, Valasek P, et al. (2010) Neuromuscular
junction morphology, ﬁber-type proportions, and satellite-cell
proliferation rates are altered in MyoD(-/-) mice. Muscle Nerve
42, 38–52.
59. Caiozzo VJ, Wu YZ, Baker MJ, et al. (2004) Effects of
denervation on cell cycle control in laryngeal muscle.
Arch Otolaryngol Head Neck Surg 130, 1056–1068.
60. Vissing K, Andersen JL, Harridge SD, et al. (2005) Gene
expression of myogenic factors and phenotype-speciﬁc
markers in electrically stimulated muscle of paraplegics.
J Appl Physiol 99, 164–172.
61. Coughlan MT, Yap FY, Tong DC, et al. (2011) Advanced
glycation end products are direct modulators of beta-cell
function. Diabetes 60, 2523–2532.
62. Peppa M, He C, Hattori M, et al. (2003) Fetal or neonatal
low-glycotoxin environment prevents autoimmune diabetes in
NOD mice. Diabetes 52, 1441–1448.
63. Peppa M, Brem H, Ehrlich P, et al. (2003) Adverse effects of
dietary glycotoxins on wound healing in genetically
diabetic mice. Diabetes 52, 2805–2813.
64. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, et al.
(2007) Accumulation of dietary glycotoxins in the reproduc-
tive system of normal female rats. J Mol Med 85, 1413–1420.
65. Patel R, Baker SS, Liu W, et al. (2012) Effect of dietary
advanced glycation end products on mouse liver. PLOS ONE
7, e35143.
Dietary advanced glycation end products and skeletal muscle growth 29
https://doi.org/10.1017/S0007114516004591
Downloaded from https:/www.cambridge.org/core. Kyoto University, on 29 May 2017 at 06:17:18, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
